Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non–Small Cell Lung Cancer

PaperCitations, authors & open-access status

Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 121 citations, 2018 year and bronze oa status.

121
Citations
2018
Year
bronze
OA Status

Related on ScholarIQ

Lan Shen
Author
Journal of Thoracic Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Cytokine Signaling Pathways and Interactions
Topic
470M+ articles · free account